330 related articles for article (PubMed ID: 15475627)
1. Linkage between the proteasome pathway and neurodegenerative diseases and aging.
Vigouroux S; Briand M; Briand Y
Mol Neurobiol; 2004 Oct; 30(2):201-21. PubMed ID: 15475627
[TBL] [Abstract][Full Text] [Related]
2. Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
Opoku-Nsiah KA; Gestwicki JE
Transl Res; 2018 Aug; 198():48-57. PubMed ID: 30244692
[TBL] [Abstract][Full Text] [Related]
3. Proteasome activation delays aging and protects against proteotoxicity in neurodegenerative disease.
Gonos E
Adv Exp Med Biol; 2015; 821():7. PubMed ID: 25416104
[No Abstract] [Full Text] [Related]
4. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
5. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
6. Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain.
Giannini C; Kloß A; Gohlke S; Mishto M; Nicholson TP; Sheppard PW; Kloetzel PM; Dahlmann B
PLoS One; 2013; 8(5):e64042. PubMed ID: 23667697
[TBL] [Abstract][Full Text] [Related]
7. Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process.
Tonoki A; Kuranaga E; Tomioka T; Hamazaki J; Murata S; Tanaka K; Miura M
Mol Cell Biol; 2009 Feb; 29(4):1095-106. PubMed ID: 19075009
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proteasomes in prion disease.
Zhu T; Hayat Khan S; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):531-9. PubMed ID: 24829398
[TBL] [Abstract][Full Text] [Related]
9. Advances in Proteasome Enhancement by Small Molecules.
George DE; Tepe JJ
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.
Morozov AV; Kulikova AA; Astakhova TM; Mitkevich VA; Burnysheva KM; Adzhubei AA; Erokhov PA; Evgen'ev MB; Sharova NP; Karpov VL; Makarov AA
J Alzheimers Dis; 2016 Sep; 54(2):763-76. PubMed ID: 27567864
[TBL] [Abstract][Full Text] [Related]
11. The complexity of recognition of ubiquitinated substrates by the 26S proteasome.
Ciechanover A; Stanhill A
Biochim Biophys Acta; 2014 Jan; 1843(1):86-96. PubMed ID: 23872423
[TBL] [Abstract][Full Text] [Related]
12. Proteasomes.
Dahlmann B
Essays Biochem; 2005; 41():31-48. PubMed ID: 16250896
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation.
Goldberg AL; Kim HT; Lee D; Collins GA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34067263
[TBL] [Abstract][Full Text] [Related]
14. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
15. The role of ubiquitin-proteasome system in ageing.
Löw P
Gen Comp Endocrinol; 2011 May; 172(1):39-43. PubMed ID: 21324320
[TBL] [Abstract][Full Text] [Related]
16. PA28γ: New Insights on an Ancient Proteasome Activator.
Cascio P
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
[TBL] [Abstract][Full Text] [Related]
17. An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline.
Proctor CJ; Tsirigotis M; Gray DA
BMC Syst Biol; 2007 Mar; 1():17. PubMed ID: 17408507
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
Huang Q; Figueiredo-Pereira ME
Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
[TBL] [Abstract][Full Text] [Related]
19. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.
Thibaudeau TA; Anderson RT; Smith DM
Nat Commun; 2018 Mar; 9(1):1097. PubMed ID: 29545515
[TBL] [Abstract][Full Text] [Related]
20. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
Schmitt HP
Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
